IL-15 that a regulator of TNF-α in patients with diabetes mellitus type 2

Medical Hypotheses

Volumn 80, Issue 6, 2013, Pages 776-777

  Sánchez Jiménez, Roberto ^a   Alvarado Vásquez, Noé ^b  

^a Higher School of Medicine of National Polytechnic Institute   (Mexico)

^b National Institute of Respiratory Diseases   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 15; LIPID; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTICLE; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; MOLECULAR MECHANICS; MUSCLE ATROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PROTEIN DEGRADATION; SKELETAL MUSCLE;

ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; EXERCISE THERAPY; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-15; MOTOR ACTIVITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877150817     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.03.009     Document Type: Article

References (30)

1. Choi K., Kim Y.B. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med 2010, 25:119-129.
2. Gauthier M.S., Ruderman N.B. Adipose tissue inflammation and insulin resistance: all obese humans are not created equal. Biochem J 2010, 430:e1-e4.
3. Mavridis G., Souliou E., Symeonidis G., Pastore F., Vassiliou A.M., Karamitsos D. Inflammatory cytokines in insulin-treated patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2008, 18:471-476.
4. Hummasti S., Hotamisligil G.S. Endoplasmic reticulum stress and inflammation in obesity and diabetes. Cir Res 2010, 107:579-591.
5. Kalupahana N.S., Moustaid-Moussa N., Claycombe K.J. Immunity as a link between obesity and insulin resistance. Mol Aspects Med 2012, 33:26-34.
6. Shoelson S.E., Herrero L., Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007, 132:2169-2180.
7. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 2006, 116:1793-1801.
8. Feinstein R., Kanety H., Papa M.Z., Lunenfeld B., Karasik A. Tumor necrosis factor-a suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993, 268:26055-26058.
9. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011, 29:415-445.
10. Luca C., Olefsky J.M. Inflammation and insulin resistance. FEBS Lett 2008, 582:97-105.
11. Musi N., Goodyear L.J. Insulin resistance and improvements in signal transduction. Endocrine 2006, 29:73-80.
12. Rosado-Pérez J., Mendoza-Núñez V.M. Chronic inflammation and oxidative stress in diabetes mellitus. Bioquimia 2007, 32:58-69.
13. Cruz M., Velasco E., Kumate J. Intracellular signals intervening in glucose control. Gac Méd Méx 2001, 137:135-146.
14. Nieto-Vázquez I., Fernández-Veledo S., Keamer D.K., Vila-Bedmar R., García-Guerra L., Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem 2008, 114:183-194.
15. Argilés J., López -Soriano F.J., Busquets S. Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposity. Drug Discov Today 2009, 14:208-213.
16. Busquets S., Figueras M.T., Meijsing S., et al. Interleukin-15 decreases proteolysis in skeletal muscle: a direct effect. Int J Mol Med 2005, 16:471-476.
17. Carbo N., Lopez-Soriano J., Costelli P., et al. Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim Biophys Acta 2001, 1526:17-24.
18. Tamura Y., Watanabe K., Kantani T., Hayashi J., Ishida N., Kaneki M. Up-regulation of circulating IL-15 by treadmill running in healthy individuals: is IL-15 an endocrine mediator of the beneficial effects of endurance exercise?. Endocr J 2011, 58:211-215.
19. Nielsen A.R., Hojman P., Erikstrup C., et al. Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab 2008, 93:4486-4493.
20. Quinn L.S. Interleukin-15: a muscle-derived cytokine regulating fat-to-lean body composition. J Anim Sci 2008, 86:E75-E83.
21. Santos S.A. IL-15: a relevant cytokine for lymphoid homeostasis and autoimmune diseases. Biotecnol. Apl. 2006, 23:79-86.
22. Gonzalez A.I., Ortiz A.M., Tomero E.G., et al. The therapeutic blockade of TNF reduces serum levels of interleukin 15 in patients with rheumatoid arthritis. Reumatol Clin 2009, 5:23-27.
23. Kuczynski S., Winiarska H., Abramczyk M., Szczawinska K., Wierusz-Wysocka B., Dworacka M. IL-15 is elevated in serum patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 2005, 69:231-236.
24. Mclnnes I., Alastair G. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 2004, 4:392-397.
25. Duarte P.M., Santos V.R., Dos Santos F.A., De Lima Pereira S.A., Rodriguez D.B., Napimoga M.H. Role of smoking and type 2 diabetes in the immunobalance of advanced chronic periodontitis. J Periodontol 2011, 82:429-438.
26. Argilés J.M., Busquets S., Felipe A., López-Soriano F.J. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol 2005, 37:1084-1104.
27. Barra N.G., Chew M.V., Holloway A.C., Ashkar A.A. Interleukin-15 treatment improves glucose homeostasis and insulin sensitivity in obese mice. Diabetes Obes Metab 2012, 14:190-193.
28. Pedersen B.K., Åkerström T.C.A., Nielsen A.R., Fischer C.P. Role of myokines in exercise and metabolism. J Appl Physiol 2007, 103:1093-1098.
29. Dandona P., Chaudhuri A., Mohanty P., Ghanim H. Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care 2007, 10:511-517.
30. Balducci S., Zanuso S., Nicolucci A., Fernando F., et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis 2010, 20:608-617.